<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 28.7

Trends in U.S. Mortalitya Using the Joinpoint Regression Program,

1975-2010 With up to Five Joinpoints By Primary Cancer Site, Race and Age at Death

All Races, Ages 0-14
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-98 -2.9* 1998-03 0.2 2003-10 -2.4*             -2.4*
Bone & Joint 1975-89 -3.5* 1989-10 -0.4                 -0.4
Brain & Other nervous system 1975-10 -1.0*                     -1.0*
Hodgkin lymphoma 1975-10 -4.8*                     -4.8*
Kidney & Renal pelvis 1975-92 -3.9* 1992-10 -1.3*                 -1.3*
Leukemia 1975-98 -4.0* 1998-10 -2.0*                 -2.0*
Acute lymphocytic leukemia 1975-93 -5.3* 1993-10 -2.9*                 -2.9*
Non-Hodgkin lymphoma 1975-10 -5.0*                     -5.0*
Soft tissue 1975-77 23.6 1977-10 -1.3*                 -1.3*
All Races, Ages 0-19
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-98 -2.7* 1998-02 0.3 2002-10 -2.4*             -2.4*
Bone & Joint 1975-89 -3.1* 1989-10 -0.3                 -0.3
Brain & Other nervous system 1975-10 -1.1*                     -1.1*
Hodgkin lymphoma 1975-10 -4.9*                     -4.9*
Kidney & Renal pelvis 1975-92 -3.6* 1992-10 -1.2*                 -1.2*
Leukemia 1975-89 -3.9* 1989-92 -0.8 1992-98 -5.0* 1998-01 1.1 2001-10 -3.2*     -3.2*
Acute lymphocytic leukemia 1975-82 -3.0* 1982-88 -6.4* 1988-10 -3.1*             -3.1*
Non-Hodgkin lymphoma 1975-10 -4.1*                     -4.1*
Soft tissue 1975-79 8.9* 1979-10 -1.0*                 -1.0*
White, Ages 0-14
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-96 -3.0* 1996-10 -1.2*                 -1.2*
Bone & Joint 1975-89 -3.1* 1989-10 -0.5                 -0.5
Brain & Other nervous system 1975-10 -0.9*                     -0.9*
Hodgkin lymphoma - -                     -
Kidney & Renal pelvis 1975-10 -2.6*                     -2.6*
Leukemia 1975-90 -4.5* 1990-10 -2.8*                 -2.8*
Acute lymphocytic leukemia 1975-91 -5.5* 1991-10 -2.8*                 -2.8*
Non-Hodgkin lymphoma 1975-10 -5.0*                     -5.0*
Soft tissue 1975-79 12.7* 1979-95 -2.8* 1995-10 0.5             0.5
White, Ages 0-19
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-98 -2.7* 1998-03 0.3 2003-10 -2.7*             -2.7*
Bone & Joint 1975-89 -2.7* 1989-10 -0.3                 -0.3
Brain & Other nervous system 1975-10 -1.0*                     -1.0*
Hodgkin lymphoma 1975-10 -4.9*                     -4.9*
Kidney & Renal pelvis 1975-10 -2.4*                     -2.4*
Leukemia 1975-88 -4.1* 1988-10 -2.7*                 -2.7*
Acute lymphocytic leukemia 1975-82 -3.3* 1982-88 -6.6* 1988-10 -2.8*             -2.8*
Non-Hodgkin lymphoma 1975-10 -4.2*                     -4.2*
Soft tissue 1975-79 11.5* 1979-96 -1.6* 1996-10 0.1             0.1
Black, Ages 0-14
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-96 -2.6* 1996-10 -1.4*                 -1.4*
Bone & Joint 1975-81 -10.3* 1981-10 -0.7                 -0.7
Brain & Other nervous system 1975-10 -1.2*                     -1.2*
Hodgkin lymphoma - -                     -
Kidney & Renal pelvis 1975-10 -2.7*                     -2.7*
Leukemia 1975-10 -3.2*                     -3.2*
Acute lymphocytic leukemia 1975-10 -4.8*                     -4.8*
Non-Hodgkin lymphoma 1975-10 -4.5*                     -4.5*
Soft tissue 1975-10 -1.3*                     -1.3*
Black, Ages 0-19
Site Joinpoint Trend 1 Joinpoint Trend 2 Joinpoint Trend 3 Joinpoint Trend 4 Joinpoint Trend 5 Joinpoint Trend 6 AAPCb
Years APC Years APC Years APC Years APC Years APC Years APC 2006-10
All Sites 1975-10 -2.1*                     -2.1*
Bone & Joint 1975-84 -6.6* 1984-10 -0.4                 -0.4
Brain & Other nervous system 1975-10 -1.2*                     -1.2*
Hodgkin lymphoma - -                     -
Kidney & Renal pelvis 1975-10 -2.4*                     -2.4*
Leukemia 1975-10 -2.8*                     -2.8*
Acute lymphocytic leukemia 1975-82 0.1 1982-10 -4.8*                 -4.8*
Non-Hodgkin lymphoma 1975-10 -3.4*                     -3.4*
Soft tissue 1975-10 -1.0*                     -1.0*

Footnotes:

Joinpoint Regression Program Version 4.0.3, April 2013, National Cancer Institute. (https://surveillance.cancer.gov/joinpoint/).

The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Trends are from US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.

b The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2010.

* The APC/AAPC is significantly different from zero (p<.05).

- Joinpoint regression line analysis could not be performed on data series.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.